COVID-19 Vaccine Participant Develops Neurological Symptoms, AstraZeneca Pauses Trial
On Tuesday, AstraZeneca announced a pause on its experimental COVID-19 vaccine trial after a woman in the UK developed a “suspected serious reaction.” The company is also conducting trials in the U.S., South Africa and Brazil, with enrollment in all these countries on hold for now.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed